Indefinite Delivery Contract 75D30126D20720

Seqirus USA Inc. (UEI: N6U7P2B9VHS5) was awarded a multiple-award Indefinite Delivery Contract with a ceiling value of $86.5 million by the Centers for Disease Control and Prevention (CDC) to supply adult influenza vaccines through February 28, 2027. This civilian procurement, awarded December 31, 2025, supports the CDC's vaccine distribution requirements without utilization of small business set-asides. The contract represents Seqirus's established position as a critical federal vaccine supplier, with the company providing comprehensive influenza vaccine formulations including quadrivalent vaccines, multi-dose vials, and pre-filled syringes to multiple federal agencies including the Department of Veterans Affairs, Department of Defense, and Indian Health Service. Delivery locations include CDC centralized distribution centers, with firm-fixed-price delivery orders issued as needed under the Indefinite Delivery/Indefinite Quantity structure.

The underlying solicitation (75D30125R73357), posted August 14, 2025, sought proposals from FDA-licensed pediatric vaccine manufacturers to supply influenza vaccines for children ages zero through eighteen under the Vaccine for Children program, which provides vaccines to Medicaid-eligible, uninsured, American Indian/Alaska Native, and underinsured children. The combined ceiling across all awarded contracts was limited to either six million doses or $710 million, whichever threshold was reached first, with individual contract minimums of 100 doses and maximums of 30 million doses per contract. Vaccines required a shelf life extending no earlier than June 30, 2027, with anticipated delivery beginning Fall 2026. The solicitation incorporated small business subcontracting participation goals of 12.17 percent and included evaluation criteria for technical compliance, pricing, and past performance.